Tustin, CA, United States of America

Ashok Yeshwant Gore

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Spectrum Pharmaceuticals, Inc., Unicycive Therapeutics, Inc., Other. Active years: 2015-2022.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ashok Yeshwant Gore: Innovator in Lanthanum Compounds

Introduction

Ashok Yeshwant Gore is a notable inventor based in Tustin, CA (US). He has made significant contributions to the field of chemistry, particularly in the development of lanthanum compounds. With a total of 3 patents to his name, his work has implications for medical treatments, especially in managing hyperphosphatemia.

Latest Patents

Gore's latest patents include innovative methods for producing lanthanum carbonate hydroxide and lanthanum oxycarbonate. These inventions focus on improving the properties of these compounds, utilizing water-soluble lanthanum and non-alkali metal carbonates or bicarbonates. The resulting materials serve as effective phosphate binders, which can be used individually or in treatments for patients suffering from hyperphosphatemia.

Career Highlights

Throughout his career, Ashok Yeshwant Gore has worked with various companies, including Spectrum Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to advancements in pharmaceutical applications of lanthanum compounds.

Collaborations

Gore has collaborated with notable professionals in his field, including Edward A Schauer and Matthew J Stewart. These collaborations have further enriched his research and development efforts.

Conclusion

Ashok Yeshwant Gore's innovative work in lanthanum compounds highlights his significant role as an inventor. His contributions continue to impact the medical field, particularly in the treatment of hyperphosphatemia.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…